Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleOriginal Article

Meta-Analysis of Prostate-Specific Antigen and Digital Rectal Examination as Screening Tests for Prostate Carcinoma

Kishor Mistry and Greg Cable
The Journal of the American Board of Family Practice March 2003, 16 (2) 95-101; DOI: https://doi.org/10.3122/jabfm.16.2.95
Kishor Mistry
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Greg Cable
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. ↵
    Greenelee RT, Hill-Harmon MB, Murry T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001; 51: 15–36.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    Godley PA. Prostate cancer screening: promise and peril—a review. Cancer Detect Prev 1999; 23: 316–24.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    Jubelirer SJ, Tierney JP, Oliver S, et al. The value of prostatic specific antigen in prostate cancer screening in the community. W Va Med J 1994; 90: 140–2.
    OpenUrl
  4. ↵
    Marwick C. Global review of diet and cancer links available. JAMA 1997; 278: 1650–1.
    OpenUrlCrossRefPubMed
  5. ↵
    Maattanen L, Auvinen A, Stenman UH, et al. European randomized study of prostate cancer screening: first-year results of the Finnish trial. Br J Cancer 1999; 79: 1210–4.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    Kuriyama M, Wang MC, Papsidero LD, et al. Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. Cancer Res 1980; 40: 4658–62.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Higashihara E, Nutahara K, Kojima M, et al. Significance of free prostate-specific antigen and gamma-seminoprotein in the screening of prostate cancer. Prostate Suppl 1996; 7: 40–7.
    OpenUrlPubMed
  8. ↵
    Jewett HJ, Bridge RW, Gray GF Jr, Shelley WM. The palpable nodule of prostatic cancer. Results of 15 years after radical excision. JAMA 1968; 203: 403–6.
    OpenUrlCrossRefPubMed
  9. ↵
    Osterling JE. Early detection of prostate cancer. Decreasing the mortality rate. Minn Med 1996; 79: 46–9.
    OpenUrl
  10. Guide to clinical preventive services. 2nd ed. Report of the US Preventive Services Task Force. Baltimore, Md: Williams & Wilkins 1996: 119–34.
  11. Kramer BS, Brown ML, Prorok PC, Potosky AL, Gohagan JK. Prostate cancer screening: what we know and what we need to know. Ann Intern Med 1993; 119: 914–23.
    OpenUrlPubMedWeb of Science
  12. Woolf HS. Screening for prostate cancer with prostate-specific antigen: an examination of evidence. N Engl J Med 1995; 333: 1401–5.
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    Zoorob R, Anderson R, Cefalu C, Sidani M. Cancer screening guidelines. Am J Fam Physician 2001; 63: 1101–12.
    OpenUrl
  14. ↵
    Bangma CH, Kranse R, Blijenberg BG, Schroder F. The value of screening tests in the detection of prostate cancer. Part II: retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density. Urology 1995; 46: 779–84.
    OpenUrlCrossRefPubMedWeb of Science
  15. Brett TD. An analysis of digital rectal examination and serum-prostate-specific antigen in the early detection of prostate cancer in general practice. Fam Pract 1998; 15: 529–33.
    OpenUrlAbstract/FREE Full Text
  16. Bretton PR. Prostate-specific antigen and digital rectal examination in screening for prostate cancer: a community-based study. South Med J 1994; 87: 720–3.
    OpenUrlCrossRefPubMed
  17. ↵
    Gustafsson O, Mansour E, Norming U, Carlsson A, Tomblom M, Nyman CR. Prostate-specific antigen (PSA), PSA density and age-adjusted PSA reference values in screening for prostate cancer—a study of a randomly selected population of 2,400 men. Scand J Urol Nephrol 1998; 32: 373–7.
    OpenUrlPubMed
  18. Horninger W, Reissigl A, Rogatsch H, et al. Prostate cancer screening in Tyrol, Australia: experience and results. Eur Urol 1999; 35: 523–38.
    OpenUrlPubMed
  19. Imai K, Ichinose Y, Kubota Y, et al. Clinical significance of prostate specific antigen for early stage prostate cancer detection. Jpn J Clin Oncol 1994; 24: 160–5.
    OpenUrlAbstract/FREE Full Text
  20. Imai K, Ichinose Y, Kubota Y, Yamanaka H, Sato J. Diagnostic significance of prostate specific antigen and the development of a mass screening system for prostate cancer. J Urol 1995; 154: 1085–9.
    OpenUrlCrossRefPubMedWeb of Science
  21. Reissigl A, Pointner J, Horninger W, et al. PSA-based screening for prostate cancer in asymptomatic younger males: pilot study in blood donors. Prostate 1997; 30: 20–5.
    OpenUrlCrossRefPubMedWeb of Science
  22. Stenman UH, Hakama M, Knekt P, Aromaa A, Teppo L, Leinonen J. Serum concentrations of prostatic specific antigen and its complex with alpha1-antichymotrypsin before diagnosis of prostate cancer. Lancet 1994; 344: 1594–8.
    OpenUrlCrossRefPubMedWeb of Science
  23. Tsukamoto T, Kumamoto Y, Masumori N, et al. Mass screening for prostate carcinoma: a study in Hokkaido, Japan. Eur Urol 1995; 27: 177–81.
    OpenUrlPubMed
  24. ↵
    Cochran WG. Sampling techniques. 3rd ed. New York: John Wiley & Sons, 1977: 89–96.
  25. ↵
    Woolf HS. Prostate cancer: to screen or not to screen? Commentary. Oncology 1997; 11: 451–2.
    OpenUrl
  26. ↵
    Tornblom M, Norming U, Adolfsson J, et al. Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3 ng/mL. Urology 1999; 53: 945–50.
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    Lodding P, Aus G, Bergdahl S, et al. Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng/mL prostate-specific antigen. J Urol 1998; 159: 899–903.
    OpenUrlCrossRefPubMedWeb of Science
  28. ↵
    Svetec D, Thompson IM. PSA screening—current controversy. Ann Oncol 1998; 9: 1283–8.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    Scardino PT. Early detection of prostate cancer. Urol Clin North Am 1989; 16: 635–55.
    OpenUrlPubMedWeb of Science
  30. ↵
    Rationale for randomised trials of prostate cancer screening. The International Prostate Screening Trial Evaluation Group. Eur J Cancer 1999; 35: 262–71.
  31. ↵
    Zappa M, Ciatto S, Bonardi R, Mazzotta A. Overdiagnosis of prostate carcinoma by screening: An estimate based on the results of the Florence screening pilot study. Ann Oncol 1998; 9: 1297–1300.
    OpenUrlAbstract/FREE Full Text
  32. ↵
    Brawer MK. prostate-specific antigen. Diagn Clin Testing 1990; 28: 16–21.
    OpenUrl
  33. ↵
    Oesterling JE. Prostate-specific antigen. Cancer 1995; 75: 1795–1804.
    OpenUrlCrossRef
  34. ↵
    Statistical abstract of the United States. 17th ed. US Department of Commerce, Economics and Statistics Administration, Bureau of the Census. Lantham, Md: Bernan Press, 1997: 15.
  35. ↵
    de Koning HJ, Auvinen A, Berenguer Sanchez AB, et al. Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial. Int J Cancer 2002; 97: 237–44.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family Practice: 16 (2)
The Journal of the American Board of Family Practice
Vol. 16, Issue 2
1 Mar 2003
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Meta-Analysis of Prostate-Specific Antigen and Digital Rectal Examination as Screening Tests for Prostate Carcinoma
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Meta-Analysis of Prostate-Specific Antigen and Digital Rectal Examination as Screening Tests for Prostate Carcinoma
Kishor Mistry, Greg Cable
The Journal of the American Board of Family Practice Mar 2003, 16 (2) 95-101; DOI: 10.3122/jabfm.16.2.95

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Meta-Analysis of Prostate-Specific Antigen and Digital Rectal Examination as Screening Tests for Prostate Carcinoma
Kishor Mistry, Greg Cable
The Journal of the American Board of Family Practice Mar 2003, 16 (2) 95-101; DOI: 10.3122/jabfm.16.2.95
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Conclusions
    • Acknowledgments
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Assessment of Prostate Volume and Prostate-specific Antigen Density With the Segmentation Method on Magnetic Resonance Imaging
  • A Caenorhabditis elegans behavioral assay distinguishes early stage prostate cancer patient urine from controls
  • Prediction models for prostate cancer to be used in the primary care setting: a systematic review
  • Circulating Tumor Cell Counts in Patients With Localized Prostate Cancer Including Those Under Active Surveillance
  • Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI
  • Methylation panel is a diagnostic biomarker for Barretts oesophagus in endoscopic biopsies and non-endoscopic cytology specimens
  • Digital Rectal Examination for Prostate Cancer Screening in Primary Care: A Systematic Review and Meta-Analysis
  • Knowledge and practice of prostate cancer screening among general practitioners in Malaysia: a cross-sectional study
  • Combined PET/MRI Improves Diagnostic Accuracy in Patients with Prostate Cancer: A Prospective Diagnostic Trial
  • Multicenter Evaluation of [-2]Proprostate-Specific Antigen and the Prostate Health Index for Detecting Prostate Cancer
  • TMPRSS2-ERG Fusion Transcripts in Matched Urine and Needle Rinse Material after Biopsy for the Detection of Prostate Cancer: Really a Step Forward?
  • The liver pharmacological and xenobiotic gene response repertoire
  • Google Scholar

More in this TOC Section

  • Screening for Dementia: Family Caregiver Questionnaires Reliably Predict Dementia
  • Help-Seeking for Insomnia among Adult Patients in Primary Care
  • How Much Time Do Patients with Diabetes Spend on Self-Care?
Show more Original Articles

Similar Articles

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire